Novartis_3 on EU
![]() | VIII | 1,582 | 46.90% | 1,056 | 942 | 399 | 0.60 | 19.66% | — | −23% | ||||
![]() | VIII | 1,266 | 49.45% | 1,115 | 1,090 | 387 | 0.71 | 20.30% | — | — | −19% | |||
![]() | IX | 524 | 43.70% | 915 | 1,136 | 428 | 0.52 | 14.31% | — | — | −15% | |||
![]() | VIII | 515 | 48.54% | 1,011 | 953 | 449 | 0.61 | 15.53% | — | −9% | ||||
![]() | VIII | 500 | 45.20% | 873 | 920 | 344 | 0.53 | 14.40% | — | −16% | ||||
![]() | VII | 483 | 47.00% | 639 | 594 | 40 | 0.50 | 38.72% | — | −29% | ||||
![]() | VIII | 467 | 48.82% | 917 | 950 | 334 | 0.63 | 24.63% | — | −13% | ||||
![]() | VII | 461 | 48.59% | 767 | 587 | 325 | 0.61 | 12.36% | — | — | −22% | |||
![]() | VII | 453 | 45.25% | 874 | 706 | 294 | 0.62 | 18.54% | — | −1% | ||||
![]() | VIII | 441 | 43.54% | 528 | 430 | 530 | 0.23 | 4.99% | — | — | −28% | |||
![]() | VIII | 440 | 47.50% | 1,060 | 997 | 492 | 0.69 | 28.41% | — | −8% | ||||
![]() | X | 426 | 41.31% | 929 | 1,430 | 701 | 0.51 | 15.26% | — | −17% | ||||
![]() | VI | 414 | 47.58% | 753 | 478 | 196 | 0.59 | 18.84% | — | −14% | ||||
![]() | VIII | 406 | 43.84% | 705 | 727 | 377 | 0.46 | 11.33% | — | — | −28% | |||
![]() | VIII | 404 | 51.73% | 1,048 | 974 | 425 | 0.62 | 27.23% | — | −16% | ||||
![]() | VI | 376 | 46.81% | 928 | 577 | 52 | 0.73 | 37.77% | — | — | −13% | |||
![]() | IX | 375 | 48.80% | 968 | 1,197 | 447 | 0.69 | 21.33% | — | −21% | ||||
![]() | IX | 366 | 42.08% | 1,138 | 1,363 | 472 | 0.64 | 18.85% | — | +10% | ||||
![]() | VII | 351 | 49.57% | 1,027 | 837 | 282 | 0.67 | 16.24% | — | −3% | ||||
![]() | V | 327 | 46.79% | 668 | 237 | 303 | 0.42 | 5.50% | — | −20% | ||||
![]() | VI | 317 | 54.57% | 1,052 | 609 | 318 | 0.70 | 18.30% | — | — | −20% | |||
![]() | VIII | 307 | 48.86% | 841 | 841 | 394 | 0.59 | 21.50% | — | −21% | ||||
![]() | VIII | 294 | 43.20% | 819 | 824 | 445 | 0.51 | 12.24% | — | — | −28% | |||
![]() | VII | 283 | 45.94% | 909 | 794 | 281 | 0.69 | 17.67% | — | −11% | ||||
![]() | X | 270 | 44.44% | 817 | 1,266 | 591 | 0.56 | 15.19% | — | — | −33% |